A signature for pan-cancer prognosis based on neutrophil extracellular traps
Top Cited Papers
Open Access
- 10 June 2022
- journal article
- research article
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 10 (6) , e004210
Abstract
Background Neutrophil extracellular traps (NETs) were originally thought to be formed by neutrophils to trap invading microorganisms as a defense mechanism. Increasing studies have shown that NETs play a pivotal role in tumor progression and diffusion. In this case, transcriptome analysis provides an opportunity to unearth the association between NETs and clinical outcomes of patients with pan-cancer. Methods The transcriptome sequencing data of The Cancer Genome Atlas pan-cancer primary focus was obtained from UCSC Xena, and a 19-gene NETs score was then constructed using the Least Absolute Shrinkage and Selection Operator (LASSO) Cox regression model based on the expression levels of 69 NETs initial biomarkers we collected from multistudies. In addition, multiple datasets covering multiple cancer types from other databases were collected and used to validate the signature. Gene ontology enrichment analyses were used to annotate the functions of NETs-related pathways. Immunohistochemistry (IHC) was implemented to evaluate the role of NETs-related genes in clinical patients across types of tumors, including lung adenocarcinoma (n=58), colorectal carcinoma (n=93), kidney renal clear cell carcinoma (n=90), and triple-negative breast cancer (n=80). Results The NETs score was calculated based on 19-NETs related genes according to the LASSO Cox model. The NETs score was considered a hazardous factor in most cancer types, with a higher score indicating a more adverse outcome. In addition, we found that NETs were significantly correlated to various malignant biological processes, such as the epithelial to mesenchymal transition (R=0.7444, pConclusions Collectively, these constitutive and complementary biomarkers represented the ability of NETs formation to predict the development of patients’ progression. Integrative transcriptome analyses plus clinical sample validation may facilitate the biomarker discovery and clinical transformation.Keywords
Funding Information
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences (2021-I2M-1-014)
- Natural Science Foundation of Beijing Municipality (7212083)
- National Natural Science Foundation of China (81972317, 81972318, 82072837)
This publication has 46 references indexed in Scilit:
- Olfactomedin 4 defines a subset of human neutrophilsJournal of Leukocyte Biology, 2011
- Tumor-infiltrating neutrophils in pancreatic neoplasiaLaboratory Investigation, 2011
- Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinomaAngiogenesis, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunityBlood, 2011
- Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular trapsJournal of Cell Biology, 2010
- Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patientsLung Cancer, 2010
- Inferring Pathway Activity toward Precise Disease ClassificationPLOS Computational Biology, 2008
- Decision Curve Analysis: A Novel Method for Evaluating Prediction ModelsMedical Decision Making, 2006
- Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesisProceedings of the National Academy of Sciences, 2006